Table 2.

Engraftment of PHSCs from MI-treated or nonirradiated mice




Spleen

Source
Bone marrow
CD4 cells
CD8 cells
B cells
Thymus
From legs of non-MI-treated mice, n = 7   17.27 ± 12.27   9.33 ± 5.97   5.00 ± 4.86   15.41 ± 8.65   7.80 ± 5.56  
From legs of MI-treated mice, n = 5*  45.01 ± 11.31   34.02 ± 8.30   29.71 ± 13.43   44.51 ± 16.16   35.56 ± 15.77  
From sternum and vertebrae of MI-treated mice, n = 5*
 
49.38 ± 10.64
 
42.24 ± 7.60
 
42.32 ± 8.53
 
54.20 ± 9.90
 
46.42 ± 24.2
 



Spleen

Source
Bone marrow
CD4 cells
CD8 cells
B cells
Thymus
From legs of non-MI-treated mice, n = 7   17.27 ± 12.27   9.33 ± 5.97   5.00 ± 4.86   15.41 ± 8.65   7.80 ± 5.56  
From legs of MI-treated mice, n = 5*  45.01 ± 11.31   34.02 ± 8.30   29.71 ± 13.43   44.51 ± 16.16   35.56 ± 15.77  
From sternum and vertebrae of MI-treated mice, n = 5*
 
49.38 ± 10.64
 
42.24 ± 7.60
 
42.32 ± 8.53
 
54.20 ± 9.90
 
46.42 ± 24.2
 

BMCs were harvested from long-term chimera 40 weeks after BMT. BMCs (1 × 107) were injected to lethally irradiated (10 Gy) CD45.1 mice. Mice were killed 27 weeks after adoptive transfer. Values are presented as mean % donor cells ± standard deviation.

*

Significantly higher than non-MI-treated animals (P < .05).

or Create an Account

Close Modal
Close Modal